LMNL logo

Liminal BioSciences (LMNL) EBIT

Annual EBIT

-$21.80 M
+$9.00 M+29.22%

December 31, 2022


Summary


Performance

LMNL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLMNLprofitabilitymetrics:

Quarterly EBIT

-$6.69 M
-$1.08 M-19.28%

June 30, 2023


Summary


Performance

LMNL Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLMNLprofitabilitymetrics:

TTM EBIT

-$23.70 M
-$2.29 M-10.71%

June 30, 2023


Summary


Performance

LMNL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherLMNLprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

LMNL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.2%-52.1%+1.0%
3 y3 years+79.9%+28.7%-10.2%
5 y5 years+78.0%+69.3%+78.0%

LMNL EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+41.3%+52.1%+15.9%+10.7%+30.0%
5 y5-yearat high+397.8%-123.7%+186.4%+186.6%+365.2%
alltimeall time-1029.3%+748.5%-123.7%+1624.5%-695.0%+959.8%

Liminal BioSciences EBIT History

DateAnnualQuarterlyTTM
Jun 2023
-
-$6.69 M(+19.3%)
-$23.70 M(+10.7%)
Mar 2023
-
-$5.61 M(+4.9%)
-$21.41 M(-9.1%)
Dec 2022
-$21.80 M(-29.2%)
-$5.35 M(-11.6%)
-$23.56 M(-0.9%)
Sep 2022
-
-$6.05 M(+37.5%)
-$23.77 M(-0.7%)
Jun 2022
-
-$4.40 M(-43.3%)
-$23.94 M(-15.8%)
Mar 2022
-
-$7.76 M(+39.4%)
-$28.45 M(-7.7%)
Dec 2021
-$30.80 M(-10.9%)
-$5.56 M(-10.6%)
-$30.81 M(-8.7%)
Sep 2021
-
-$6.22 M(-30.1%)
-$33.74 M(-4.7%)
Jun 2021
-
-$8.90 M(-12.0%)
-$35.41 M(-1.3%)
Mar 2021
-
-$10.12 M(+19.2%)
-$35.89 M(-20.1%)
Dec 2020
-$34.58 M(-68.1%)
-$8.49 M(+7.6%)
-$44.94 M(+443.5%)
Sep 2020
-
-$7.89 M(-15.9%)
-$8.27 M(-61.6%)
Jun 2020
-
-$9.39 M(-51.0%)
-$21.51 M(-80.5%)
Mar 2020
-
-$19.17 M(-168.0%)
-$110.27 M(+2.5%)
Dec 2019
-$108.52 M(-41.3%)
$28.18 M(-233.3%)
-$107.61 M(-57.2%)
Sep 2019
-
-$21.14 M(-78.5%)
-$251.21 M(+0.1%)
Jun 2019
-
-$98.14 M(+494.3%)
-$250.91 M(+43.7%)
Mar 2019
-
-$16.51 M(-85.7%)
-$174.59 M(-4.7%)
Dec 2018
-$184.98 M(+86.8%)
-$115.42 M(+453.8%)
-$183.18 M(+66.9%)
Sep 2018
-
-$20.84 M(-4.5%)
-$109.76 M(+8.8%)
Jun 2018
-
-$21.82 M(-13.1%)
-$100.92 M(-1.1%)
Mar 2018
-
-$25.10 M(-40.2%)
-$102.02 M(+3.2%)
Dec 2017
-$99.05 M(+16.7%)
-$42.00 M(+249.9%)
-$98.87 M(+13.5%)
Sep 2017
-
-$12.00 M(-47.6%)
-$87.11 M(-9.9%)
Jun 2017
-
-$22.91 M(+4.4%)
-$96.66 M(+3.5%)
Mar 2017
-
-$21.95 M(-27.4%)
-$93.37 M(+9.8%)
Dec 2016
-$84.89 M(+84.6%)
-$30.24 M(+40.3%)
-$85.01 M(+31.9%)
Sep 2016
-
-$21.55 M(+9.9%)
-$64.45 M(+25.6%)
Jun 2016
-
-$19.62 M(+44.3%)
-$51.31 M(+18.4%)
Mar 2016
-
-$13.60 M(+40.6%)
-$43.31 M(-6.3%)
Dec 2015
-$45.99 M(-2060.3%)
-$9.67 M(+15.0%)
-$46.25 M(+48.5%)
Sep 2015
-
-$8.41 M(-27.7%)
-$31.13 M(-24.0%)
Jun 2015
-
-$11.63 M(-29.7%)
-$40.95 M(+461.6%)
Mar 2015
-
-$16.53 M(-404.0%)
-$7.29 M(-434.1%)
Dec 2014
$2.35 M(-115.7%)
$5.44 M(-129.8%)
$2.18 M(-122.8%)
Sep 2014
-
-$18.23 M(-182.7%)
-$9.59 M(-340.8%)
Jun 2014
-
$22.03 M(-412.1%)
$3.98 M(-119.7%)
Mar 2014
-
-$7.06 M(+11.4%)
-$20.19 M(+35.9%)
Dec 2013
-$14.97 M(-1513.6%)
-$6.34 M(+36.1%)
-$14.86 M(+108.8%)
Sep 2013
-
-$4.66 M(+117.3%)
-$7.12 M(-1957.9%)
Jun 2013
-
-$2.14 M(+24.1%)
$383.10 K(-89.5%)
Mar 2013
-
-$1.73 M(-222.8%)
$3.67 M(+239.5%)
Dec 2012
$1.06 M(-155.0%)
$1.41 M(-50.6%)
$1.08 M(-66.9%)
Sep 2012
-
$2.85 M(+149.7%)
$3.26 M(-338.9%)
Jun 2012
-
$1.14 M(-126.4%)
-$1.37 M(-66.6%)
Mar 2012
-
-$4.31 M(-220.2%)
-$4.09 M(+106.9%)
Dec 2011
-$1.93 M(-78.4%)
$3.59 M(-301.4%)
-$1.98 M(-78.5%)
Sep 2011
-
-$1.78 M(+12.3%)
-$9.18 M(-9.1%)
Jun 2011
-
-$1.59 M(-27.9%)
-$10.10 M(+12.4%)
Mar 2011
-
-$2.20 M(-39.2%)
-$8.98 M(-4.5%)
Dec 2010
-$8.90 M
-$3.62 M(+34.1%)
-$9.41 M(+25.0%)
Sep 2010
-
-$2.70 M(+474.8%)
-$7.53 M(+45.2%)
DateAnnualQuarterlyTTM
Jun 2010
-
-$469.40 K(-82.1%)
-$5.18 M(-38.8%)
Mar 2010
-
-$2.63 M(+51.3%)
-$8.48 M(+18.6%)
Dec 2009
-$7.23 M(-53.4%)
-$1.74 M(+389.4%)
-$7.15 M(-18.1%)
Sep 2009
-
-$354.60 K(-90.6%)
-$8.72 M(-22.4%)
Jun 2009
-
-$3.76 M(+190.3%)
-$11.24 M(-8.3%)
Mar 2009
-
-$1.30 M(-60.9%)
-$12.25 M(-22.3%)
Dec 2008
-$15.51 M(-18.1%)
-$3.31 M(+15.2%)
-$15.77 M(-15.1%)
Sep 2008
-
-$2.87 M(-39.9%)
-$18.57 M(-14.2%)
Jun 2008
-
-$4.78 M(-0.7%)
-$21.65 M(+5.1%)
Mar 2008
-
-$4.81 M(-21.3%)
-$20.59 M(+7.4%)
Dec 2007
-$18.94 M(-6.1%)
-$6.11 M(+2.7%)
-$19.17 M(+2.0%)
Sep 2007
-
-$5.95 M(+60.1%)
-$18.80 M(-1.4%)
Jun 2007
-
-$3.72 M(+9.8%)
-$19.06 M(-0.6%)
Mar 2007
-
-$3.39 M(-41.0%)
-$19.18 M(-6.9%)
Dec 2006
-$20.18 M(+63.8%)
-$5.74 M(-7.7%)
-$20.59 M(+13.0%)
Sep 2006
-
-$6.22 M(+62.0%)
-$18.22 M(+13.9%)
Jun 2006
-
-$3.84 M(-20.0%)
-$16.00 M(-1.9%)
Mar 2006
-
-$4.80 M(+42.6%)
-$16.31 M(+32.3%)
Dec 2005
-$12.32 M(+13.5%)
-$3.36 M(-15.8%)
-$12.33 M(+5.0%)
Sep 2005
-
-$4.00 M(-3.7%)
-$11.74 M(+7.5%)
Jun 2005
-
-$4.15 M(+411.6%)
-$10.92 M(+39.5%)
Mar 2005
-
-$811.70 K(-70.8%)
-$7.83 M(-28.6%)
Dec 2004
-$10.86 M(-26.3%)
-$2.78 M(-12.7%)
-$10.97 M(-13.8%)
Sep 2004
-
-$3.18 M(+200.4%)
-$12.73 M(-2.5%)
Jun 2004
-
-$1.06 M(-73.2%)
-$13.06 M(-17.8%)
Mar 2004
-
-$3.95 M(-12.9%)
-$15.90 M(+7.4%)
Dec 2003
-$14.73 M(+60.5%)
-$4.54 M(+29.5%)
-$14.81 M(+13.8%)
Sep 2003
-
-$3.51 M(-9.9%)
-$13.01 M(+12.0%)
Jun 2003
-
-$3.89 M(+36.0%)
-$11.62 M(+14.9%)
Mar 2003
-
-$2.86 M(+4.1%)
-$10.11 M(+10.2%)
Dec 2002
-$9.18 M(+67.6%)
-$2.75 M(+30.4%)
-$9.18 M(+12.5%)
Sep 2002
-
-$2.11 M(-11.7%)
-$8.16 M(+12.5%)
Jun 2002
-
-$2.39 M(+23.8%)
-$7.26 M(+15.9%)
Mar 2002
-
-$1.93 M(+11.5%)
-$6.26 M(+14.6%)
Dec 2001
-$5.48 M(+60.5%)
-$1.73 M(+43.7%)
-$5.46 M(+20.7%)
Sep 2001
-
-$1.20 M(-13.7%)
-$4.53 M(+4.7%)
Jun 2001
-
-$1.40 M(+23.3%)
-$4.32 M(+15.7%)
Mar 2001
-
-$1.13 M(+42.8%)
-$3.74 M(+13.5%)
Dec 2000
-$3.41 M(+12.7%)
-$792.70 K(-20.8%)
-$3.29 M(+87.9%)
Sep 2000
-
-$1.00 M(+23.5%)
-$1.75 M(-16.4%)
Jun 2000
-
-$810.60 K(+17.8%)
-$2.10 M(-18.6%)
Mar 2000
-
-$688.00 K(-192.1%)
-$2.58 M(-14.5%)
Dec 1999
-$3.03 M(+66.2%)
$747.30 K(-155.6%)
-$3.01 M(-28.5%)
Sep 1999
-
-$1.35 M(+4.3%)
-$4.21 M(+24.0%)
Jun 1999
-
-$1.29 M(+14.8%)
-$3.40 M(-0.7%)
Mar 1999
-
-$1.12 M(+147.6%)
-$3.42 M(-1.9%)
Dec 1998
-$1.82 M(-49.0%)
-$454.00 K(-14.1%)
-$3.49 M(-19.1%)
Sep 1998
-
-$528.60 K(-59.8%)
-$4.31 M(+14.0%)
Jun 1998
-
-$1.31 M(+10.4%)
-$3.78 M(+53.2%)
Mar 1998
-
-$1.19 M(-6.9%)
-$2.47 M(+93.1%)
Dec 1997
-
-$1.28 M
-$1.28 M
Sep 1997
-$3.58 M
-
-

FAQ

  • What is Liminal BioSciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Liminal BioSciences?
  • What is Liminal BioSciences annual EBIT year-on-year change?
  • What is Liminal BioSciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Liminal BioSciences?
  • What is Liminal BioSciences quarterly EBIT year-on-year change?
  • What is Liminal BioSciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Liminal BioSciences?
  • What is Liminal BioSciences TTM EBIT year-on-year change?

What is Liminal BioSciences annual earnings before interest & taxes?

The current annual EBIT of LMNL is -$21.80 M

What is the all time high annual EBIT for Liminal BioSciences?

Liminal BioSciences all-time high annual earnings before interest & taxes is $2.35 M

What is Liminal BioSciences annual EBIT year-on-year change?

Over the past year, LMNL annual earnings before interest & taxes has changed by +$9.00 M (+29.22%)

What is Liminal BioSciences quarterly earnings before interest & taxes?

The current quarterly EBIT of LMNL is -$6.69 M

What is the all time high quarterly EBIT for Liminal BioSciences?

Liminal BioSciences all-time high quarterly earnings before interest & taxes is $28.18 M

What is Liminal BioSciences quarterly EBIT year-on-year change?

Over the past year, LMNL quarterly earnings before interest & taxes has changed by -$2.29 M (-52.10%)

What is Liminal BioSciences TTM earnings before interest & taxes?

The current TTM EBIT of LMNL is -$23.70 M

What is the all time high TTM EBIT for Liminal BioSciences?

Liminal BioSciences all-time high TTM earnings before interest & taxes is $3.98 M

What is Liminal BioSciences TTM EBIT year-on-year change?

Over the past year, LMNL TTM earnings before interest & taxes has changed by +$237.80 K (+0.99%)